Recently, there has been increased awareness of the global burden of tuberculosis in children, resulting in more attention being given to pediatric tuberculosis from a clinical, public health, and research perspective.1,2,7-11 Improving the accuracy of the diagnosis of tuberculosis in children is made more difficult by the paucibacillary nature of their disease; the fact that the symptoms and signs they present, as well as the radiological findings, are often nonspecific; and the inability of immunodiagnostic tests (interferon-gamma release assays and tuberculin skin tests) to differentiate between infection with Mycobacterium tuberculosis and active disease. Expanding the evidence available in the scientific literature to support quality diagnostic and treatment guidelines specific to pediatrics is a core issue,1,2,7-11 as is the need to increase the availability of the child-friendly drug formulations that are now available through the Global Drug Facility of the international Stop TB Partnership.12